What Is End-of-Life Care for Desmoplastic Small Round Cell Tumor (DSRCT)?
By CRYSTAL BAI •
The short answer: DSRCT is an ultra-rare, aggressive pediatric/young adult sarcoma with peritoneal involvement. End-of-life care addresses abdominal disease, ascites, bowel obstruction, and pain through specialized palliative care, with attention to young adult and pediatric care needs.
Understanding DSRCT at End of Life
Desmoplastic small round cell tumor (DSRCT) is an ultra-rare, highly aggressive sarcoma primarily affecting male adolescents and young adults, typically arising in the peritoneum. The EWS-WT1 gene fusion is its molecular hallmark. Despite multimodal therapy, most DSRCT patients experience relapse and the median overall survival remains poor.
Peritoneal Disease and Symptom Management
Advanced DSRCT causes massive peritoneal disease — multiple tumors coating abdominal organs — leading to bowel obstruction, ascites, abdominal pain, early satiety, and malnutrition. Palliative interventions include paracentesis for ascites, endoscopic procedures for bowel obstruction, opioid analgesia for pain, and nutritional support.
The Young Patient and Pediatric Dimensions
DSRCT primarily affects adolescents and young adults — typically young men in their teens to 30s. End-of-life care must address the profound developmental disruption of dying young: interrupted education, career, relationships, and life trajectory. Parents grieving a child or young adult, and partners/siblings are significantly impacted.
Connecting With the DSRCT Community
The Ewing Sarcoma Research Foundation, the DSRCT Alliance, and rare sarcoma foundations provide patient and family community. Because DSRCT is so rare, specialists may be limited — major sarcoma centers (MD Anderson, Memorial Sloan Kettering, Boston Children's) are most experienced with this disease.
Frequently Asked Questions
What is desmoplastic small round cell tumor (DSRCT)?
DSRCT is an ultra-rare, aggressive peritoneal sarcoma primarily affecting male adolescents and young adults, with a poor prognosis despite intensive treatment.
When should a DSRCT patient consider hospice?
Hospice is appropriate when DSRCT is progressing after multimodal treatment and prognosis is six months or less, with focus on quality of life.
What symptoms are managed at end of life with DSRCT?
Key symptoms include abdominal pain, bowel obstruction, ascites, early satiety, and malnutrition from massive peritoneal disease.
Can a death doula help a young adult and family facing DSRCT end of life?
Yes. Death doulas experienced with young adult end-of-life care provide vital support for patients and families facing DSRCT's devastating impact on a young person's life.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.